Day Zero Diagnostics is Biotechnology in United States that focus on machine learning business. Founded in 2016. They cover business area such as developer, an infectious disease diagnostic system, profile antibiotic susceptibility, hour, whole-genome sequencing, machine, antibiotic resistance profile, physician, broad-spectrum antibiotic, patient, a severe infection.
2016
( 8 years old in 2024 )
Machine Learning
-
40 Guest Street
Suite 3300
Boston, MA 02135
United States
Private
developeran infectious disease diagnostic systemprofile antibiotic susceptibilityhourwhole-genome sequencingmachineantibiotic resistance profilephysicianbroad-spectrum antibioticpatienta severe infection
* We use standard office opening hours in near Day Zero Diagnostics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Day Zero Diagnostics is Biotechnology business from United States that founded in 2016 (8 years old in 2024), Day Zero Diagnostics business is focusing on Machine Learning.
Day Zero Diagnostics headquarter office and corporate office address is located in 40 Guest Street Suite 3300 Boston, MA 02135 United States.
Day Zero Diagnostics was founded in United States.
In 2024, Day Zero Diagnostics is currently focus on machine learning sector.
Above is snippet of Google Trends for "machine learning" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Day Zero Diagnostics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
